Ann‐Sofie Jemth - Concepedia

Author

Ann‐Sofie Jemth

Also Known As

A. Jemth, A.-S. Jemth, A.S. Jemth, Ann-Sofie Jemth, AnnSofie Jemth, Ann‐Sofie Jemth, Johansson, Anders, Tobias Koolmeister

109

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Science for Life Laboratory Karolinska Institutet Stockholm University University of Sheffield Uppsala University

About

Ann‐Sofie Jemth is an author at Science for Life Laboratory specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	2.2K
2	Natural Sciences	14	15	936
3	Biochemistry	13	14	780
4	Engineering	1	1	25
5	Public Health	1	1	11

Ann‐Sofie Jemth

Publications

Citations

H-Index

Page 1

	Year	Citations
PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombination Helen E. Bryant, Eva Petermann, Niklas Schultz, The EMBO Journal	2009	589
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool Helge Gad, Tobias Koolmeister, Ann‐Sofie Jemth, Nature Tumor BiologyDntp PoolMth1 InhibitionOncologyMedicine	2014	525
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy K. Huber, E. Salah, Branka Radic-Sarikas, Nature Medicinal ChemistryDrug TargetingAnticancer StrategyChemoprevention StrategyMedicine	2014	387
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation Torkild Visnes, Armando Cázares‐Körner, Wenjing Hao, Science	2018	220
A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family Jordi Carreras‐Puigvert, Marinka Žitnik, Ann‐Sofie Jemth, Nature Communications	2017	163
PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA Olga Loseva, Ann‐Sofie Jemth, Helen E. Bryant, Journal of Biological Chemistry ChromatinGenome InstabilityNucleic Acid ChemistryChromatin RemodelingNatural Sciences	2010	151
Validation and development of MTH1 inhibitors for treatment of cancer Ulrika Warpman Berglund, Kumar Sanjiv, Helge Gad, Annals of Oncology OncologyMedicinePathologyAnti-cancer AgentMetronomic Chemotherapy	2016	145
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies Nikolas Herold, Sean G. Rudd, Linda Ljungblad, Nature Medicine Hematological MalignancyTumor BiologyCytarabine TherapyNovel TherapyMedicine	2017	141
Processing of protein ADP-ribosylation by Nudix hydrolases Luca Palazzo, Benjamin Thomas, Ann‐Sofie Jemth, Biochemical Journal Protein FunctionHuman NudixBiochemistryCellular EnzymologyProtein Folding	2015	132
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine Nicholas C.K. Valerie, Anna Hagenkort, Brent D. G. Page, Cancer Research Nudt15 AblationAldo-keto ReductasePharmacotherapyTumor BiologyNudt15 Hydrolyzes	2016	127

Page 1